← TrialMatch
HomeTrials

Storage and Research Use of Human Bio-specimens From Melanoma Patients and Clinical Testin

The purpose of this research is to identify biological characteristics occurring in the initiation and progression of melanoma.

Condition(s)Melanoma
StatusRecruiting
Study typeObservational
SummaryThe purpose of this research is to identify biological characteristics occurring in the initiation and progression of melanoma.
Who can participateInclusion criteria * Pathologically-proven diagnosis of melanoma. * Patient must have a test or procedure that has the potential to provide left-over tissue that can be banked for future research purposes OR the patient has already had a diagnostic or therapeutic procedure but who has not yet been approached to participate is also eligible. Exclusion criteria * Any patient with significant contraindications to venipuncture (e.g., severe anemia) will be excluded from blood collection procedures. However, if the patient provides consent and a paraffin-embedded block or 10-15 unstained slides of their tissue diagnosis, they will not be excluded from this protocol. * Any patient unable or unwilling to provide consent.
Ages18 Years
SexAll
Lead sponsorVanderbilt-Ingram Cancer Center
LocationsNashville, Tennessee, United States
Start date2010-06-03
NCT IDNCT01205815
Official listinghttps://clinicaltrials.gov/study/NCT01205815

🔍 Search all trials →